0001209191-19-037713.txt : 20190618 0001209191-19-037713.hdr.sgml : 20190618 20190618163848 ACCESSION NUMBER: 0001209191-19-037713 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190614 FILED AS OF DATE: 20190618 DATE AS OF CHANGE: 20190618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hochberg Elaine CENTRAL INDEX KEY: 0001703059 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38137 FILM NUMBER: 19904017 MAIL ADDRESS: STREET 1: C/O AKCEA THERAPAEUTICS STREET 2: 55 CAMBRIDGE PKWY, STE 100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001662524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472608175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-207-0202 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-14 0 0001662524 AKCEA THERAPEUTICS, INC. AKCA 0001703059 Hochberg Elaine C/O AKCEA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON MA 02210 1 0 0 0 Stock Option (right to buy) 22.74 2019-06-14 4 A 0 26400 0.00 A 2029-06-13 Common Stock 26400 26400 D The shares vest over a four year period in equal annual installments beginning on June 14, 2019. /s/ Jeffrey Goldberg, Attorney-in-Fact 2019-06-17